|

Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease

RECRUITINGPhase 1/2Sponsored by Peking Union Medical College Hospital
Actively Recruiting
PhasePhase 1/2
SponsorPeking Union Medical College Hospital
Started2022-05-10
Est. completion2027-12-31
Eligibility
Age18 Years – 88 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07400224

Summary

This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinical treatment strategy guidance.

Eligibility

Age: 18 Years – 88 YearsHealthy volunteers accepted
Inclusion Criteria:

* a. Age 18 years old or above, gender not restricted. b. Have undergone a health check-up within the last 3 months (at least completed chest X-ray / chest CT and abdominal B-ultrasound and other examinations), and no major diseases were found.

Exclusion Criteria:

* As this study involves certain radiation exposure, patients who have had frequent radiation exposure due to clinical needs (those who have undergone a CT or PET/CT examination once within 3 months or 1 month respectively) are not included in the study.

Conditions4

CancerCardiovascular AbnormalitiesHyperthyroidism, AutoimmuneMalignant Tumor

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.